Myriad Genetics (MYGN): SOTP Suggesting The Company Is Undervalued (NASDAQ:MYGN)

Photo of author

By news.saerio.com


This article was written by

ywAAAAAAQABAAACAUwAOw==

I am a public markets investor and analyst focused on event-driven opportunities, activist special situations, and global macro investing. I manage an independent portfolio across equities, ETFs, options, and foreign exchange, with a research-driven approach centered on identifying asymmetric risk-reward opportunities. My investment process combines fundamental analysis with valuation frameworks such as discounted cash flow (DCF) and sum-of-the-parts (SOTP) modelling, along with governance analysis and financial restructuring assessment when evaluating companies undergoing strategic or capital structure changes. My research interests span several areas, including activist and catalyst-driven equities, macro-thematic positioning through ETFs, and selective short-selling opportunities where structural weaknesses or mispricing may exist. I also develop macro investment theses across global markets, covering equities, fixed income, commodities, and currencies. On Seeking Alpha, I intend to write about special situations, event-driven investments, macro themes affecting markets, portfolio strategy, and ETF-based positioning. While my work is cross-sector, I tend to focus on industries where corporate actions, balance sheet transformations, or macro shifts create potential dislocations in valuation. I hold a Master’s degree in Corporate Finance from Henley Business School and a Master’s degree in Business Management from Queen’s Business School. In addition to investing, I have written multiple books covering SPACs, portfolio management, and hedge fund strategies. My motivation for writing on Seeking Alpha is to share research-driven investment ideas with a global community of investors, contribute thoughtful analysis on special situations and macro developments, and engage in constructive discussions that help refine investment theses. I believe platforms like Seeking Alpha provide an excellent forum for presenting structured research, testing investment ideas in public markets, and learning from the perspectives of other experienced investors.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.



Source link

Leave a Reply